The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells

Cancer Letters

Volumn 236, Issue 1, 2006, Pages 80-88

  Lin, Shu Chun ^a   Li, Wan Chun ^a   Shih, Jing Wen ^a   Hong, Kuo Fu ^a   Pan, Yen Ru ^a   Lin, Jing Jer ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

EGC; EGCG; hTERT; Neoplasm; Tea; Telomerase

Indexed keywords

EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; MESSENGER RNA; POLYPHENOL DERIVATIVE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TEA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMELLIA SINENSIS; CATECHIN; CELL LINE, TUMOR; CELL SURVIVAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TELOMERASE; TIME FACTORS;

EID: 33646526291     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.05.003     Document Type: Article

References (24)

1. Lin J.K., and Liang Y.C. Cancer chemoprevention by tea polyphenols. Proc. Natl. Sci. Counc. Repub. China B 24 (2000) 1-13
2. Yang C.S., Maliakal P., and Meng X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 25-54
3. Liang Y.C., Lin-Shiau S.Y., Chen C.F., and Lin J.K. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J. Cell Biochem. 75 (1999) 1-12
4. Masuda M., Suzui M., and Weinstein I.B. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 7 (2001) 4220-4229
5. Li N., Chen X., Liao J., Yang G., Wang S., Josephson Y., et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23 (2002) 1307-1313
6. Greider C.W. Chromosome first aid. Cell 67 (1991) 645-647
7. Poremba C., Heine B., Diallo R., Heinecke A., Wai D., Schaefer K., et al. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J. Pathol. 198 (2002) 181-189
8. Kumaki F., Kawai T., Hiroi S., Shinomiya N., Ozeki Y., Ferrans V., et al. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Hum. Pathol. 32 (2001) 188-195
9. Naasani I., Oh-hashi F., Oh-hara T., Feng W.Y., Johnston J., Chan K., et al. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res. 63 (2003) 824-830
10. Urquidi V., Tarin D., and Goodison S. Role of telomerase in cell senescence and oncogenesis. Annu. Rev. Med. 51 (2000) 65-79
11. Cao Y., Li H., Deb S., and Liu J.P. TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene 21 (2002) 3130-3138
12. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90 (1997) 785-795
13. Mergny J.L., Riou J.F., Mailliet P., Teulade-Fichou M.P., and Gilson E. Natural and pharmacological regulation of telomerase. Nucleic Acids Res. 30 (2002) 839-865
14. Pendino F., Flexor M., Delhommeau F., Buet D., Lanotte M., and Segal-Bendirdjian E. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc. Natl. Acad. Sci. USA 98 (2001) 6662-6667
15. Lin S.C., Wang C.P., Chen Y.M., Lu S.Y., Fann M.J., Liu C.J., et al. Regulation of IGFBP-5 expression during tumorigenesis and differentiation of oral keratinocytes. J. Pathol. 198 (2002) 317-325
16. Chang K.W., Yuan T.C., Fang K.P., Yang F.S., Liu C.J., Chang C.S., et al. The increase of voltage-gated potassium channel Kv3.4 mRNA expression in oral squamous cell carcinoma. J. Oral Pathol. Med. 32 (2003) 606-611
17. Huang H.S., Chiou J.F., Fong Y., Hou C.C., Lu Y.C., Wang J.Y., et al. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone. J. Med. Chem. 46 (2003) 3300-3307
18. Ko S.Y., Lin S.C., Chang K.W., Liu C.J., Chang S.S., Lu S.Y., et al. Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract. J. Oral Pathol. Med. 32 (2003) 399-407
19. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., and Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89 (1997) 1881-1886
20. Nihal M., Ahmad N., Mukhtar H., and Wood G.S. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int. J. Cancer 114 (2005) 513-521
21. Aisner D.L., Wright W.E., and Shay J.W. Telomerase regulation: not just flipping the switch. Curr. Opin. Genet. Dev. 12 (2002) 80-85
22. Xu D., Wang Q., Gruber A., Bjorkholm M., Chen Z., Zaid A., et al. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 19 (2000) 5123-5133
23. Waltner-Law M.E., Wang X.L., Law B.K., Hall R.K., Nawano M., and Granner D.K. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J. Biol. Chem. 277 (2002) 34933-34940
24. Yang F., Oz H.S., Barve S., de Villiers W.J., McClain C.J., and Varilek G.W. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 60 (2001) 528-533